<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04582019</url>
  </required_header>
  <id_info>
    <org_study_id>05/20-Ð½</org_study_id>
    <nct_id>NCT04582019</nct_id>
  </id_info>
  <brief_title>Safety and Effectiveness of Ureteral DJ Stent With Magnet (Blackstar, Urotech) Removal Under Ultrasound Control</brief_title>
  <official_title>A Single-center Randomized, Controlled Study Evaluating Safety and Effectiveness of Ureteral dj Stent With Magnet (Blackstar, Urotech), Stent-related Symptoms and Pain Level After Stent Removal Compared With Conventional Stent Removal With Flexible Cystoscope</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Petersburg State Pavlov Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Petersburg State Pavlov Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of safety and effectiveness of ureteral DJ stent with magnet (Blackstar, Urotech),&#xD;
      severity of stent-association symptoms and pain level syndrome after stent extraction&#xD;
      compared with stent extraction by flexible cystoscope&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inclusion Criteria:&#xD;
&#xD;
        -  age from 18 to 70 years&#xD;
&#xD;
        -  males&#xD;
&#xD;
        -  Indications for rigid or flexible URS&#xD;
&#xD;
        -  ASA score: 1-3&#xD;
&#xD;
      Exclusion Criteria:&#xD;
&#xD;
        -  Active urinary tract infection&#xD;
&#xD;
        -  taking alpha-1 adreno and M-cholinoblockers&#xD;
&#xD;
      All patients will be randomized into 2 groups:&#xD;
&#xD;
        -  group A - male patients who will undergo ureteral stent placement by conventional&#xD;
           polyurethane DJ stent, Fr 6.5. N=30&#xD;
&#xD;
        -  group B - male patients who will undergo ureteral stent placement by polyurethane DJ&#xD;
           stent with magnet (Blackstar, Urotech ), Fr 7. N=30 Patients are to be assigned a&#xD;
           randomization number that will match their treatment. Block randomization using 10&#xD;
           blocks is to be performed by a central randomization organization (www.randomize.net)&#xD;
           using a computerized algorithm.&#xD;
&#xD;
      Using the Visual Analog Scale of Pain (VASP) and Ureteric Stent Symptom Questionnaire (USSQ)&#xD;
      we are going to assess the pain syndrome and the severity of stent-associated symptoms. The&#xD;
      USSQ will be filled twice: 3 days after stent placement and on the day of stent removal, just&#xD;
      before the procedure. All stents will be removed 30 days after placement. Also, immediately&#xD;
      after stent removal, patients will complete the VASP questionnaire. In the control group, the&#xD;
      stent will be removed using flexible cystoscopy. In the experimental group under ultrasound&#xD;
      control using a magnetic retriever, with a bladder capacity of at least 150 ml.&#xD;
&#xD;
      Primary assessed outcomes:&#xD;
&#xD;
        1. Age&#xD;
&#xD;
        2. Body mass index&#xD;
&#xD;
        3. Operation side&#xD;
&#xD;
        4. The density of the stone&#xD;
&#xD;
        5. Type of the operation&#xD;
&#xD;
        6. Applying of the ureteral accessing sheath&#xD;
&#xD;
        7. Type of the ureteral stent&#xD;
&#xD;
        8. Troubles with stent placement&#xD;
&#xD;
        9. USSQ (Ureteral stent symptom questionnaire) 3 days after surgery&#xD;
&#xD;
       10. USSQ before stent extraction&#xD;
&#xD;
       11. VASP (Visual Analog Scale Pain) immediately after stent extraction&#xD;
&#xD;
       12. Duration of stent extractiom by magnetic retrieval device&#xD;
&#xD;
       13. Duration of stent extraction by cystoscopy&#xD;
&#xD;
       14. Stent removal success (yes/no)&#xD;
&#xD;
      Secondary assessed outcomes:&#xD;
&#xD;
        1. Assessment of Stone-free status after surgery by performing computed tomography of&#xD;
           kidneys and urinary tract without intravenous contrasting 1 month after surgery&#xD;
&#xD;
        2. Stent encrustation&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 14, 2020</start_date>
  <completion_date type="Anticipated">April 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>group A - male patients who will undergo ureteral stent placement by conventional polyurethane DJ stent, Fr 6.5. N=30&#xD;
group B - male patients who will undergo ureteral stent placement by polyurethane DJ stent with magnet (Blackstar, Urotech ), Fr 7. N=30</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>Patients are to be assigned a randomization number that will match their treatment. Block randomization using 10 blocks is to be performed by a central randomization organization (www.randomize.net) using a computerized algorithm.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Stent-related symptoms (SRS)</measure>
    <time_frame>30 days</time_frame>
    <description>Using USSQ to evaluate the difference of SRS in patients with different types of stent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body pain</measure>
    <time_frame>30 days</time_frame>
    <description>Using VASP to evaluate the pain level in patients with different types of stent extraction</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Urolithiasis</condition>
  <arm_group>
    <arm_group_label>Patients with polyurethane DJ stent</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Polyurethane DJ stent, 6Fr. The stent will be removed using flexible cystoscopy.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with polyurethane DJ stent with magnet</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Polyurethane DJ stent with magnet (Blackstar, Urotech), 7Fr. The stent will be removed under ultrasound control using a magnetic retriever</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>stent extraction</intervention_name>
    <description>stent extraction using magnetic retriever or flexible cystoscope</description>
    <arm_group_label>Patients with polyurethane DJ stent</arm_group_label>
    <arm_group_label>Patients with polyurethane DJ stent with magnet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age from 18 to 70 years&#xD;
&#xD;
          -  males&#xD;
&#xD;
          -  Indications for rigid or flexible URS&#xD;
&#xD;
          -  ASA score: 1-3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Active urinary tract infection&#xD;
&#xD;
          -  taking alpha-1 adreno and M-cholinoblockers&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Dmitry S Gorelov</last_name>
    <phone>+79217964892</phone>
    <email>dsgorelov@mail.ru</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Vladimir M Obidniak</last_name>
    <phone>+79218944746</phone>
    <email>v.obidniak@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>First Pavlov Saint Petersburg University</name>
      <address>
        <city>Saint Petersburg</city>
        <zip>197342</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dmitriy Gorelov, MD</last_name>
      <phone>+79217964892</phone>
      <email>dsgorelov@mail.ru</email>
    </contact>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 25, 2020</study_first_submitted>
  <study_first_submitted_qc>October 3, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 9, 2020</study_first_posted>
  <last_update_submitted>October 26, 2020</last_update_submitted>
  <last_update_submitted_qc>October 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>St. Petersburg State Pavlov Medical University</investigator_affiliation>
    <investigator_full_name>nariman.gadjiev</investigator_full_name>
    <investigator_title>Head of endourology department</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Urolithiasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

